Grail vs MDxHealth
GRAL and MDXH side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How GRAL and MDXH compare
Grail grew revenue faster over the last twelve months (23.1% versus 19.8% for MDxHealth).
MDxHealth keeps more of each dollar of sales as profit, with a net margin of −31.1% compared with −237% at Grail.
Grail scores higher on the StockData Score (10 against 5 for MDxHealth), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | GRAL | MDXH |
|---|---|---|
| Size and price | ||
| Market cap | $4.7B | – |
| Share price | $105.88 | $0.149 |
| Change, 1 year | 33.0% | −95.9% |
| Change, 5 years | – | −98.4% |
| Beta (5Y) | 2.06 | 3.13 |
| Employees | 910 | 364 |
| StockData Score | ||
| Total score | 10 (better) | 5 |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 1 | 1 |
| Health score | 6 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 28.6× | – |
| P/B | 1.9× | – |
| FCF yield | −6.3% | – |
| Growth | ||
| Revenue growth (TTM) | 23.1% (better) | 19.8% |
| Revenue growth, 5Y average | – | 42.3% |
| Profitability | ||
| Gross margin | – | 64.5% |
| Operating margin | −338% | −13.4% (better) |
| Net margin | −237% | −31.1% (better) |
| FCF margin | −179% | −3.1% (better) |
| Return on equity | −16.1% | – |
| Return on invested capital | −26.0% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −0.6× |
| Current ratio | 10.95 (better) | 1.08 |
| Altman Z-score | 4.06 | – |
| Piotroski F-score | 5 (better) | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 87.6% | 32.3% |
| Held by insiders | 11.0% | – |
| Insider net buying, 12 months | −$38.3M | $991K (better) |
| Short interest, % of float | 20.1% | – |
Go deeper
- GRAL stock overview
- GRAL income statement
- GRAL valuation and score
- MDXH stock overview
- MDXH income statement
- MDXH valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.